Extracochlear neurostimulation - Auricle

Sensorineural hearing loss is an increasingly prevalent condition that causes disability to over a third of US adults aged over 65. As the condition progresses, it selectively affects high-frequency hearing that is critical for speech comprehension. For the 1.2M US adults with bilateral severe-to-profound high-frequency loss the only available treatment is a cochlear implant, however the risk of residual hearing loss associated with this irreversible procedure leads most patients to forgo treatment. We are developing a breakthrough device to restore high-frequency hearing that preserves residual hearing through a reversible and minimally invasive approach.

This project was renewed in 2022.